The University of Chicago Header Logo

Takemasa Tsuji

TitleResearch Associate Professor
InstitutionUniversity of Chicago
DepartmentObstetrics and Gynecology-Gynecologic Oncology
AddressChicago IL 60637
vCardDownload vCard

    Collapse Bibliographic 
    Collapse selected publications
    Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Faculty can login to make corrections and additions.
    Newest   |   Oldest   |   Most Cited   |   Most Discussed   |   Timeline   |   Field Summary   |   Plain Text
    PMC Citations indicate the number of times the publication was cited by articles in PubMed Central, and the Altmetric score represents citations in news articles and social media. (Note that publications are often cited in additional ways that are not shown here.) Fields are based on how the National Library of Medicine (NLM) classifies the publication's journal and might not represent the specific topic of the publication. Translation tags are based on the publication type and the MeSH terms NLM assigns to the publication. Some publications (especially newer ones and publications not in PubMed) might not yet be assigned Field or Translation tags.) Click a Field or Translation tag to filter the publications.
    1. Fan H, Xia S, Xiang J, Li Y, Ross MO, Lim SA, Yang F, Tu J, Xie L, Dougherty U, Zhang FQ, Zheng Z, Zhang R, Wu R, Dong L, Su R, Chen X, Althaus T, Riedell PA, Jonker PB, Muir A, Lesinski GB, Rafiq S, Dhodapkar MV, Stock W, Odenike O, Patel AA, Opferman J, Tsuji T, Matsuzaki J, Shah H, Faubert B, Elf SE, Layden B, Bissonnette BM, He YY, Kline J, Mao H, Odunsi K, Gao X, Chi H, He C, Chen J. Trans-vaccenic acid reprograms CD8+ T cells and anti-tumour immunity. Nature. 2023 Nov; 623(7989):1034-1043. PMID: 37993715; PMCID: PMC10686835.
      Citations: 2     Fields:    Translation:HumansAnimalsCells
    2. Vylegzhanina AV, Bespalov IA, Novototskaya-Vlasova KA, Hall BM, Gleiberman AS, Yu H, Leontieva OV, Leonova KI, Kurnasov OV, Osterman AL, Dy GK, Komissarov AA, Vasilieva E, Gehlhausen J, Iwasaki A, Ambrosone CB, Tsuji T, Matsuzaki J, Odunsi K, Andrianova EL, Gudkov AV. Cancer Relevance of Circulating Antibodies Against LINE-1 Antigens in Humans. Cancer Res Commun. 2023 11 08; 3(11):2256-2267. PMID: 37870410; PMCID: PMC10631453.
      Citations:    Translation:HumansCells
    3. Dong B, Obermajer N, Tsuji T, Matsuzaki J, Bonura C, Withers H, Long M, Chavel C, Olejniczak SH, Minderman H, Edwards RP, Storkus WJ, Romero P, Kalinski P. NK Receptors Replace CD28 As the Dominant Source of Signal 2 for Cognate Recognition of Cancer Cells by TAA-specific Effector CD8+ T Cells. Res Sq. 2023 Oct 19. PMID: 37886562; PMCID: PMC10602189.
    4. McGray AJR, Chiello JL, Tsuji T, Long M, Maraszek K, Gaulin N, Rosario SR, Hess SM, Abrams SI, Kozbor D, Odunsi K, Zsiros E. BiTE secretion by adoptively transferred stem-like T cells improves FRa+ ovarian cancer control. J Immunother Cancer. 2023 06; 11(6). PMID: 37647218; PMCID: PMC10314690.
      Citations: 1     Fields:    Translation:HumansCells
    5. Mohammadpour H, Tsuji T, MacDonald CR, Sarow JL, Rosenheck H, Daneshmandi S, Choi JE, Qiu J, Matsuzaki J, Witkiewicz AK, Attwood K, Blazar BR, Odunsi K, Repasky EA, McCarthy PL. Galectin-3 expression in donor T cells reduces GvHD severity and lethality after allogeneic hematopoietic cell transplantation. Cell Rep. 2023 03 28; 42(3):112250. PMID: 36924493; PMCID: PMC10116561.
      Citations: 2     Fields:    Translation:HumansAnimalsCells
    6. Zangari B, Tsuji T, Matsuzaki J, Mohammadpour H, Eppolito C, Battaglia S, Ito F, Chodon T, Koya R, Robert McGray AJ, Odunsi K. Correction to: Tcf-1 protects anti-tumor TCR-engineered CD8+ T-cells from GzmB mediated self-destruction. Cancer Immunol Immunother. 2022 Dec; 71(12):2899. PMID: 35666273; PMCID: PMC9588465.
      Citations:    Fields:    
    7. Tsuji T, Matsuzaki J, Odunsi K. Tissue residency of memory CD8+ T cells matters in shaping immunogenicity of ovarian cancer. Cancer Cell. 2022 05 09; 40(5):452-454. PMID: 35537410.
      Citations: 1     Fields:    Translation:HumansCells
    8. Zangari B, Tsuji T, Matsuzaki J, Mohammadpour H, Eppolito C, Battaglia S, Ito F, Chodon T, Koya R, Robert McGray AJ, Odunsi K. Tcf-1 protects anti-tumor TCR-engineered CD8+ T-cells from GzmB mediated self-destruction. Cancer Immunol Immunother. 2022 Dec; 71(12):2881-2898. PMID: 35460379; PMCID: PMC9588092.
      Citations:    Fields:    Translation:HumansCells
    9. Odunsi K, Qian F, Lugade AA, Yu H, Geller MA, Fling SP, Kaiser JC, Lacroix AM, D'Amico L, Ramchurren N, Morishima C, Disis ML, Dennis L, Danaher P, Warren S, Nguyen VA, Ravi S, Tsuji T, Rosario S, Zha W, Hutson A, Liu S, Lele S, Zsiros E, McGray AJR, Chiello J, Koya R, Chodon T, Morrison CD, Putluri V, Putluri N, Mager DE, Gunawan R, Cheever MA, Battaglia S, Matsuzaki J. Metabolic adaptation of ovarian tumors in patients treated with an IDO1 inhibitor constrains antitumor immune responses. Sci Transl Med. 2022 03 16; 14(636):eabg8402. PMID: 35294258; PMCID: PMC9311231.
      Citations: 18     Fields:    Translation:HumansAnimals
    10. Matsuzaki J, Lele S, Odunsi K, Tsuji T. Identification of Claudin 6-specific HLA class I- and HLA class II-restricted T cell receptors for cellular immunotherapy in ovarian cancer. Oncoimmunology. 2022; 11(1):2020983. PMID: 35003898; PMCID: PMC8741298.
      Citations: 4     Fields:    Translation:HumansCells
    11. Matsuzaki J, Lele S, Odunsi K, Tsuji T. Identification of Claudin 6-specific HLA class I- and HLA class II-restricted T cell receptors for cellular immunotherapy in ovarian cancer. Oncoimmunology. 2022; 11(1):2020983.
    12. Muthuswamy R, McGray AR, Battaglia S, He W, Miliotto A, Eppolito C, Matsuzaki J, Takemasa T, Koya R, Chodon T, Lichty BD, Shrikant P, Odunsi K. CXCR6 by increasing retention of memory CD8+ T cells in the ovarian tumor microenvironment promotes immunosurveillance and control of ovarian cancer. J Immunother Cancer. 2021 10; 9(10). PMID: 34607898; PMCID: PMC8491420.
      Citations: 17     Fields:    Translation:HumansAnimalsCells
    13. Amobi-McCloud A, Muthuswamy R, Battaglia S, Yu H, Liu T, Wang J, Putluri V, Singh PK, Qian F, Huang RY, Putluri N, Tsuji T, Lugade AA, Liu S, Odunsi K. IDO1 Expression in Ovarian Cancer Induces PD-1 in T Cells via Aryl Hydrocarbon Receptor Activation. Front Immunol. 2021; 12:678999. PMID: 34025677; PMCID: PMC8136272.
      Citations: 24     Fields:    Translation:HumansAnimalsCells
    14. Want MY, Tsuji T, Singh PK, Thorne JL, Matsuzaki J, Karasik E, Gillard B, Cortes Gomez E, Koya RC, Lugade A, Odunsi K, Battaglia S. WHSC1/NSD2 regulates immune infiltration in prostate cancer. J Immunother Cancer. 2021 02; 9(2). PMID: 33589522; PMCID: PMC7887377.
      Citations: 10     Fields:    Translation:HumansAnimalsCells
    15. Tsuji T, Eng KH, Matsuzaki J, Battaglia S, Szender JB, Miliotto A, Gnjatic S, Bshara W, Morrison CD, Lele S, Emerson RO, Wang J, Liu S, Robins H, Lugade AA, Odunsi K. Clonality and antigen-specific responses shape the prognostic effects of tumor-infiltrating T cells in ovarian cancer. Oncotarget. 2020 Jul 07; 11(27):2669-2683. PMID: 32676168; PMCID: PMC7343634.
      Citations: 9     Fields:    
    16. Liu S, Matsuzaki J, Wei L, Tsuji T, Battaglia S, Hu Q, Cortes E, Wong L, Yan L, Long M, Miliotto A, Bateman NW, Lele SB, Chodon T, Koya RC, Yao S, Zhu Q, Conrads TP, Wang J, Maxwell GL, Lugade AA, Odunsi K. Efficient identification of neoantigen-specific T-cell responses in advanced human ovarian cancer. J Immunother Cancer. 2019 06 20; 7(1):156. PMID: 31221207; PMCID: PMC6587259.
      Citations: 46     Fields:    Translation:HumansCells
    17. Want MY, Konstorum A, Huang RY, Jain V, Matsueda S, Tsuji T, Lugade A, Odunsi K, Koya R, Battaglia S. Neoantigens retention in patient derived xenograft models mediates autologous T cells activation in ovarian cancer. Oncoimmunology. 2019; 8(6):e1586042. PMID: 31069153; PMCID: PMC6492964.
      Citations: 10     Fields:    
    18. Matsuzaki J, Tsuji T, Chodon T, Ryan C, Koya RC, Odunsi K. A rare population of tumor antigen-specific CD4+CD8+ double-positive aß T lymphocytes uniquely provide CD8-independent TCR genes for engineering therapeutic T cells. J Immunother Cancer. 2019 01 09; 7(1):7. PMID: 30626427; PMCID: PMC6325755.
      Citations: 7     Fields:    Translation:HumansAnimalsCells
    19. Tsuji T, Yoneda A, Matsuzaki J, Miliotto A, Ryan C, Koya RC, Odunsi K. Rapid Construction of Antitumor T-cell Receptor Vectors from Frozen Tumors for Engineered T-cell Therapy. Cancer Immunol Res. 2018 05; 6(5):594-604. PMID: 29588318; PMCID: PMC5932240.
      Citations: 8     Fields:    Translation:HumansAnimalsCells
    20. Szender JB, Eng KH, Matsuzaki J, Miliotto A, Gnjatic S, Tsuji T, Odunsi K. HLA superfamily assignment is a predictor of immune response to cancer testis antigens and survival in ovarian cancer. Gynecol Oncol. 2016 07; 142(1):158-162. PMID: 27103177; PMCID: PMC4917411.
      Citations: 5     Fields:    Translation:Humans
    21. Matsuzaki J, Tsuji T, Luescher IF, Shiku H, Mineno J, Okamoto S, Old LJ, Shrikant P, Gnjatic S, Odunsi K. Direct tumor recognition by a human CD4(+) T-cell subset potently mediates tumor growth inhibition and orchestrates anti-tumor immune responses. Sci Rep. 2015 Oct 08; 5:14896. PMID: 26447332; PMCID: PMC4597193.
      Citations: 45     Fields:    Translation:HumansAnimalsCells
    22. Eng KH, Weir I, Tsuji T, Odunsi K. Immuno-stimultory/regulatory gene expression patterns in advanced ovarian cancer. Genes Cancer. 2015 Sep; 6(9-10):399-407. PMID: 26622942; PMCID: PMC4633167.
      Citations: 3     
    23. Zsiros E, Tsuji T, Odunsi K. Adoptive T-cell therapy is a promising salvage approach for advanced or recurrent metastatic cervical cancer. J Clin Oncol. 2015 May 10; 33(14):1521-2. PMID: 25847926.
      Citations: 13     Fields:    Translation:HumansCells
    24. Kuze N, Ishikawa A, Kono M, Kobayashi T, Fuchisawa N, Tsuji T, Takeuchi H. Molecular structure and internal rotation of CF3 group of methyl trifluoroacetate: gas electron diffraction, microwave spectroscopy, and quantum chemical calculation studies. J Phys Chem A. 2015 Mar 05; 119(9):1774-86. PMID: 25437246.
      Citations:    Fields:    
    25. Eng KH, Tsuji T. Differential antigen expression profile predicts immunoreactive subset of advanced ovarian cancers. PLoS One. 2014; 9(11):e111586. PMID: 25380171; PMCID: PMC4224408.
      Citations: 5     Fields:    Translation:HumansCells
    26. Daudi S, Eng KH, Mhawech-Fauceglia P, Morrison C, Miliotto A, Beck A, Matsuzaki J, Tsuji T, Groman A, Gnjatic S, Spagnoli G, Lele S, Odunsi K. Expression and immune responses to MAGE antigens predict survival in epithelial ovarian cancer. PLoS One. 2014; 9(8):e104099. PMID: 25101620; PMCID: PMC4125181.
      Citations: 45     Fields:    Translation:Humans
    27. Odunsi K, Matsuzaki J, James SR, Mhawech-Fauceglia P, Tsuji T, Miller A, Zhang W, Akers SN, Griffiths EA, Miliotto A, Beck A, Batt CA, Ritter G, Lele S, Gnjatic S, Karpf AR. Epigenetic potentiation of NY-ESO-1 vaccine therapy in human ovarian cancer. Cancer Immunol Res. 2014 Jan; 2(1):37-49. PMID: 24535937; PMCID: PMC3925074.
      Citations: 96     Fields:    Translation:HumansCellsCTClinical Trials
    28. Matsuzaki J, Tsuji T, Luescher I, Old LJ, Shrikant P, Gnjatic S, Odunsi K. Nonclassical antigen-processing pathways are required for MHC class II-restricted direct tumor recognition by NY-ESO-1-specific CD4(+) T cells. Cancer Immunol Res. 2014 Apr; 2(4):341-50. PMID: 24764581; PMCID: PMC4004114.
      Citations: 25     Fields:    Translation:HumansCells
    29. Kitano S, Tsuji T, Liu C, Hirschhorn-Cymerman D, Kyi C, Mu Z, Allison JP, Gnjatic S, Yuan JD, Wolchok JD. Enhancement of tumor-reactive cytotoxic CD4+ T cell responses after ipilimumab treatment in four advanced melanoma patients. Cancer Immunol Res. 2013 Oct; 1(4):235-44. PMID: 24396833; PMCID: PMC3880021.
      Citations: 59     Fields:    Translation:HumansCells
    30. Tsuji T, Sabbatini P, Jungbluth AA, Ritter E, Pan L, Ritter G, Ferran L, Spriggs D, Salazar AM, Gnjatic S. Effect of Montanide and poly-ICLC adjuvant on human self/tumor antigen-specific CD4+ T cells in phase I overlapping long peptide vaccine trial. Cancer Immunol Res. 2013 Nov; 1(5):340-50. PMID: 24777970.
      Citations: 32     Fields:    Translation:HumansCellsCTClinical Trials
    31. Hirayama M, Nishikawa H, Nagata Y, Tsuji T, Kato T, Kageyama S, Ueda S, Sugiyama D, Hori S, Sakaguchi S, Ritter G, Old LJ, Gnjatic S, Shiku H. Overcoming regulatory T-cell suppression by a lyophilized preparation of Streptococcus pyogenes. Eur J Immunol. 2013 Apr; 43(4):989-1000. PMID: 23436617.
      Citations: 6     Fields:    Translation:HumansCells
    32. Sabbatini P, Tsuji T, Ferran L, Ritter E, Sedrak C, Tuballes K, Jungbluth AA, Ritter G, Aghajanian C, Bell-McGuinn K, Hensley ML, Konner J, Tew W, Spriggs DR, Hoffman EW, Venhaus R, Pan L, Salazar AM, Diefenbach CM, Old LJ, Gnjatic S. Phase I trial of overlapping long peptides from a tumor self-antigen and poly-ICLC shows rapid induction of integrated immune response in ovarian cancer patients. Clin Cancer Res. 2012 Dec 01; 18(23):6497-508. PMID: 23032745.
      Citations: 134     Fields:    Translation:HumansCellsCTClinical Trials
    33. Neumann A, Brand K, Wahle C, Siegel E, Maeurer M, Ritter E, Tsuji T, Gnjatic S, Old LJ, Ritter G, Karbach J, Jäger E. Phase I clinical trial of mixed bacterial vaccine (Coley's toxins) in patients with NY-ESO-1 expressing cancers: immunological effects and clinical activity. Clin Cancer Res. 2012 Oct 01; 18(19):5449-59. PMID: 22847809.
      Citations: 36     Fields:    Translation:HumansCellsCTClinical Trials
    34. Tsuji T, Gnjatic S. Split T-cell tolerance as a guide for the development of tumor antigen-specific immunotherapy. Oncoimmunology. 2012 May 01; 1(3):405-407. PMID: 22737632; PMCID: PMC3382850.
      Citations: 3     Fields:    
    35. Tsuji T, Matsuzaki J, Caballero OL, Jungbluth AA, Ritter G, Odunsi K, Old LJ, Gnjatic S. Heat shock protein 90-mediated peptide-selective presentation of cytosolic tumor antigen for direct recognition of tumors by CD4(+) T cells. J Immunol. 2012 Apr 15; 188(8):3851-8. PMID: 22427632.
      Citations: 19     Fields:    Translation:HumansCells
    36. Tsuji T, Matsuzaki J, Ritter E, Miliotto A, Ritter G, Odunsi K, Old LJ, Gnjatic S. Split T cell tolerance against a self/tumor antigen: spontaneous CD4+ but not CD8+ T cell responses against p53 in cancer patients and healthy donors. PLoS One. 2011; 6(8):e23651. PMID: 21858191; PMCID: PMC3155555.
      Citations: 9     Fields:    Translation:HumansCells
    37. Tsuji T, Matsuzaki J, Kelly MP, Ramakrishna V, Vitale L, He LZ, Keler T, Odunsi K, Old LJ, Ritter G, Gnjatic S. Antibody-targeted NY-ESO-1 to mannose receptor or DEC-205 in vitro elicits dual human CD8+ and CD4+ T cell responses with broad antigen specificity. J Immunol. 2011 Jan 15; 186(2):1218-27. PMID: 21149605.
      Citations: 67     Fields:    Translation:HumansCells
    38. Matsuzaki J, Gnjatic S, Mhawech-Fauceglia P, Beck A, Miller A, Tsuji T, Eppolito C, Qian F, Lele S, Shrikant P, Old LJ, Odunsi K. Tumor-infiltrating NY-ESO-1-specific CD8+ T cells are negatively regulated by LAG-3 and PD-1 in human ovarian cancer. Proc Natl Acad Sci U S A. 2010 Apr 27; 107(17):7875-80. PMID: 20385810; PMCID: PMC2867907.
      Citations: 449     Fields:    Translation:HumansCells
    39. Tsuji T, Altorki NK, Ritter G, Old LJ, Gnjatic S. Characterization of preexisting MAGE-A3-specific CD4+ T cells in cancer patients and healthy individuals and their activation by protein vaccination. J Immunol. 2009 Oct 01; 183(7):4800-8. PMID: 19734225.
      Citations: 19     Fields:    Translation:HumansCells
    40. Howland SW, Tsuji T, Gnjatic S, Ritter G, Old LJ, Wittrup KD. Inducing efficient cross-priming using antigen-coated yeast particles. J Immunother. 2008 Sep; 31(7):607-19. PMID: 18600183; PMCID: PMC2820298.
      Citations: 8     Fields:    Translation:HumansAnimalsCells
    41. Nishikawa H, Tsuji T, Briones G, Ritter G, Old LJ, Shiku H, Gnjatic S, Jäger E, Galán JE. Induction of regulatory T cell-resistant helper CD4+ T cells by bacterial vector. Blood. 2008 Feb 01; 111(3):1404-12. PMID: 17986662.
      Citations: 9     Fields:    Translation:HumansCells
    42. Satoh T, Tsuji T, Matsuda H, Sudoh S. DFT calculations and IR studies on 2-hydroxy-1,4-naphthoquinone and its 3-substituted derivatives. Bull Chem Soc Jpn. 2007; 80:321-323.
    43. Satoh T, Kudoh M, Tsuji T, Kita S, Mori T, Sudoh S. Theoretical and experimental studies on the ground- and excited-state dipole moments of 1,4-naphthoquinone and its derivatives. Bull Chem Soc Jpn. 2007; 80:1103-1113.
    44. Nishikawa H, Qian F, Tsuji T, Ritter G, Old LJ, Gnjatic S, Odunsi K. Influence of CD4+CD25+ regulatory T cells on low/high-avidity CD4+ T cells following peptide vaccination. J Immunol. 2006 May 15; 176(10):6340-6. PMID: 16670346.
      Citations: 19     Fields:    Translation:HumansCells
    45. Matsuzaki J, Tsuji T, Zhang Y, Wakita D, Imazeki I, Sakai T, Ikeda H, Nishimura T. 1alpha,25-Dihydroxyvitamin D3 downmodulates the functional differentiation of Th1 cytokine-conditioned bone marrow-derived dendritic cells beneficial for cytotoxic T lymphocyte generation. Cancer Sci. 2006 Feb; 97(2):139-47. PMID: 16441425.
      Citations: 6     Fields:    Translation:AnimalsCells
    46. Matsuzaki J, Tsuji T, Imazeki I, Ikeda H, Nishimura T. Immunosteroid as a regulator for Th1/Th2 balance: its possible role in autoimmune diseases. Autoimmunity. 2005 Aug; 38(5):369-75. PMID: 16227152.
      Citations: 18     Fields:    Translation:HumansAnimalsCells
    47. Tsuji T, Yasukawa M, Matsuzaki J, Ohkuri T, Chamoto K, Wakita D, Azuma T, Niiya H, Miyoshi H, Kuzushima K, Oka Y, Sugiyama H, Ikeda H, Nishimura T. Generation of tumor-specific, HLA class I-restricted human Th1 and Tc1 cells by cell engineering with tumor peptide-specific T-cell receptor genes. Blood. 2005 Jul 15; 106(2):470-6. PMID: 15790789.
      Citations: 35     Fields:    Translation:HumansCells
    48. Suzuki Y, Wakita D, Chamoto K, Narita Y, Tsuji T, Takeshima T, Gyobu H, Kawarada Y, Kondo S, Akira S, Katoh H, Ikeda H, Nishimura T. Liposome-encapsulated CpG oligodeoxynucleotides as a potent adjuvant for inducing type 1 innate immunity. Cancer Res. 2004 Dec 01; 64(23):8754-60. PMID: 15574787.
      Citations: 37     Fields:    Translation:AnimalsCells
    49. Hoshino A, Tsuji T, Matsuzaki J, Jinushi T, Ashino S, Teramura T, Chamoto K, Tanaka Y, Asakura Y, Sakurai T, Mita Y, Takaoka A, Nakaike S, Takeshima T, Ikeda H, Nishimura T. STAT6-mediated signaling in Th2-dependent allergic asthma: critical role for the development of eosinophilia, airway hyper-responsiveness and mucus hypersecretion, distinct from its role in Th2 differentiation. Int Immunol. 2004 Oct; 16(10):1497-505. PMID: 15351784.
      Citations: 29     Fields:    Translation:AnimalsCells
    50. Ikeda H, Chamoto K, Tsuji T, Suzuki Y, Wakita D, Takeshima T, Nishimura T. The critical role of type-1 innate and acquired immunity in tumor immunotherapy. Cancer Sci. 2004 Sep; 95(9):697-703. PMID: 15471553.
      Citations: 38     Fields:    Translation:HumansAnimalsCells
    51. Chamoto K, Takeshima T, Kosaka A, Tsuji T, Matsuzaki J, Togashi Y, Ikeda H, Nishimura T. NKT cells act as regulatory cells rather than killer cells during activation of NK cell-mediated cytotoxicity by alpha-galactosylceramide in vivo. Immunol Lett. 2004 Aug 15; 95(1):5-11. PMID: 15325792.
      Citations: 5     Fields:    Translation:AnimalsCells
    52. Yamamoto S, Tsuji T, Matsuzaki J, Zhange Y, Chamoto K, Kosaka A, Togashi Y, Sekikawa K, Sawada K, Takeshima T, Koike T, Nishimura T. Unexpected role of TNF-alpha in graft versus host reaction (GVHR): donor-derived TNF-alpha suppresses GVHR via inhibition of IFN-gamma-dependent donor type-1 immunity. Int Immunol. 2004 Jun; 16(6):811-7. PMID: 15126416.
      Citations:    Fields:    Translation:HumansAnimalsCells
    53. Fujimura T, Chamoto K, Tsuji T, Sato T, Yokouchi H, Aiba S, Tagami H, Tanaka J, Imamura M, Togashi Y, Koda T, Nishimura T. Generation of leukemia-specific T-helper type 1 cells applicable to human leukemia cell-therapy. Immunol Lett. 2004 Apr 30; 93(1):17-25. PMID: 15134894.
      Citations:    Fields:    Translation:HumansCells
    54. Gyobu H, Tsuji T, Suzuki Y, Ohkuri T, Chamoto K, Kuroki M, Miyoshi H, Kawarada Y, Katoh H, Takeshima T, Nishimura T. Generation and targeting of human tumor-specific Tc1 and Th1 cells transduced with a lentivirus containing a chimeric immunoglobulin T-cell receptor. Cancer Res. 2004 Feb 15; 64(4):1490-5. PMID: 14973062.
      Citations: 16     Fields:    Translation:HumansAnimalsCells
    55. Sato T, Saito R, Jinushi T, Tsuji T, Matsuzaki J, Koda T, Nishimura Si, Takeshima H, Nishimura T. IFN-gamma-induced SOCS-1 regulates STAT6-dependent eotaxin production triggered by IL-4 and TNF-alpha. Biochem Biophys Res Commun. 2004 Feb 06; 314(2):468-75. PMID: 14733929.
      Citations: 6     Fields:    Translation:AnimalsCells
    56. Tsuji T, Chamoto K, Gyobu H, Ikeda H, Nishimura T. Application of genetically engineered tumor-specific Th1 cells to adoptive tumor immunotherapy. Annals of Cancer Research and Therapy. 2004; 12:71-86.
    57. Chamoto K, Tsuji T, Funamoto H, Kosaka A, Matsuzaki J, Sato T, Abe H, Fujio K, Yamamoto K, Kitamura T, Takeshima T, Togashi Y, Nishimura T. Potentiation of tumor eradication by adoptive immunotherapy with T-cell receptor gene-transduced T-helper type 1 cells. Cancer Res. 2004 Jan 01; 64(1):386-90. PMID: 14729649.
      Citations: 18     Fields:    Translation:HumansAnimalsCells
    58. Chamoto K, Kosaka A, Tsuji T, Matsuzaki J, Sato T, Takeshima T, Iwakabe K, Togashi Y, Koda T, Nishimura T. Critical role of the Th1/Tc1 circuit for the generation of tumor-specific CTL during tumor eradication in vivo by Th1-cell therapy. Cancer Sci. 2003 Oct; 94(10):924-8. PMID: 14556668.
      Citations: 19     Fields:    Translation:AnimalsCells
    59. Sekimoto M, Tsuji T, Matsuzaki J, Chamoto K, Koda T, Nemoto K, Degawa M, Nishimura S, Nishimura T. Functional expression of the TrkC gene, encoding a high affinity receptor for NT-3, in antigen-specific T helper type 2 (Th2) cells. Immunol Lett. 2003 Sep 08; 88(3):221-6. PMID: 12941481.
      Citations: 11     Fields:    Translation:AnimalsCells
    60. Matsuzaki J, Tsuji T, Chamoto K, Takeshima T, Sendo F, Nishimura T. Successful elimination of memory-type CD8+ T cell subsets by the administration of anti-Gr-1 monoclonal antibody in vivo. Cell Immunol. 2003 Aug; 224(2):98-105. PMID: 14609575.
      Citations: 31     Fields:    Translation:AnimalsCellsPHPublic Health
    61. Sasaki K, Tsuji T, Jinushi T, Matsuzaki J, Sato T, Chamoto K, Togashi Y, Koda T, Nishimura T. Differential regulation of VLA-2 expression on Th1 and Th2 cells: a novel marker for the classification of Th subsets. Int Immunol. 2003 Jun; 15(6):701-10. PMID: 12750354.
      Citations: 10     Fields:    Translation:AnimalsCells
    62. Tsuji T, Chamoto K, Funamoto H, Kosaka A, Matsuzaki J, Abe H, Fujio K, Yamamoto K, Kitamura T, Togashi Y, Koda T, Nishimura T. An efficient method to prepare T cell receptor gene-transduced cytotoxic T lymphocytes type 1 applicable to tumor gene cell-therapy. Cancer Sci. 2003 Apr; 94(4):389-93. PMID: 12824910.
      Citations: 1     Fields:    Translation:AnimalsCells
    63. Kuze N, Kobayashi K, Masuda Y, Hamada T, Salaizumi T, Ohashi O, Tsuji T, Egawa T, Konaka S. Molecular structure of 1,3-dichloropropanone by gas-phase electron diffraction combined with ab initio calculations. J Mol Struct. 2002; 612:171-180.
    64. Sato M, Chamoto K, Tsuji T, Iwakura Y, Togashi Y, Koda T, Nishimura T. Th1 cytokine-conditioned bone marrow-derived dendritic cells can bypass the requirement for Th functions during the generation of CD8+ CTL. J Immunol. 2001 Oct 01; 167(7):3687-91. PMID: 11564783.
      Citations: 2     Fields:    Translation:AnimalsCells
    65. Takaoka A, Tanaka Y, Tsuji T, Jinushi T, Hoshino A, Asakura Y, Mita Y, Watanabe K, Nakaike S, Togashi Y, Koda T, Matsushima K, Nishimura T, Takaoka A, Tanaka Y, Tsuji T, Jinushi T, Hoshino A, Asakura Y, Mita Y, Watanabe K, Nakaike S, Togashi Y, Koda T, Matsushima K, Nishimura T. A critical role for mouse CXC chemokine(s) in pulmonary neutrophilia during Th type 1-dependent airway inflammation. J Immunol. 2001 Aug 15; 167(4):2349-53. PMID: 11490024.
      Citations: 19     Fields:    Translation:AnimalsCells
    66. Tsuji T, Takeuchi H, Egawa T, Konaka S. Effects of molecular structure on the stability of a thermotropic liquid crystal. Gas electron diffraction study of the molecular structure of phenyl benzoate. J Am Chem Soc. 2001 Jul 04; 123(26):6381-7. PMID: 11427064.
      Citations: 1     Fields:    
    67. Tsuji T, Takashima H, Takeuchi H, Egawa T, Konaka S. Molecular structure and torsional potential of trans-azobenzene. A gas electron diffraction study. J Phys Chem A. 2001; 105:9347-9353.
    68. Tsuji T, Takashima H, Takeuchi H, Egawa T, Konaka S. Molecular structure of trans-azoxybenzene determined by gas electron diffraction combined with ab initio calculations. J Mol Struct. 2000; 54:203-210.
    69. Tsuji T, Ito H, Takeuchi H, Konaka S. Molecular structure and conformation of methyl methacrylate determined by gas-phase electron diffraction. J Mol Struct. 1999; 475:55-63.
    70. Takeuchi H, Sato M, Tsuji T, Egawa T, Konaka S. Structural study of benzamide by gas phase electron diffraction combined with ab initio calculations. J Mol Struct. 1999; 485-486:175-181.
    71. Takeuchi H, Matsuoka T, Tsuji T, Takashima H, Ito M, Konaka S. Inductive and steric effects on the gas-phase structure of tert-butyl formate. Electron diffraction and theoretical investigations. J Mol Struct. 1998; 471:275-281.
    Tsuji's Networks
    Click the
    buttons for more information and interactive visualizations!
    Concepts (307)
    Co-Authors (10)
    Similar People (60)
    Same Department Expand Description
    Physical Neighbors